Obesità: via libera del CHMP a una nuova dose di semaglutide
Il Comitato per i Medicinali per Uso Umano (CHMP) dell’Agenzia Europea per i Medicinali (EMA) ha espresso parere positivo per un dosaggio più elevato di semaglutide, ovvero semaglutide 7,2 mg,…
NIH study finds infection-related hospitalizations linked to increased risk of heart failure
A study funded by the National Institutes of Health has found that adults who were hospitalized for a severe infection, such as respiratory infections or sepsis, were more than twice…